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Kenneth Eaton – Chair
Ladies and gentlemen I would like to welcome you. It is great
that there are so many of you here.
The panel is made up of four editors: Will Giannobile, Rex
Holland, Stephen Hancocks and Peter Robinson. The proposal
is that we think about how research publishing is going to
progress in the next 20 years. The proceedings are being
recorded and it is the intention to publish them as a record for
the future. A huge number of issues may or may not be
relevant. The ones that are now on the screen have been
suggested by our panel. I will quickly run through them just to
get you thinking:
 Open (or free) access
 Expert analysis
 Vast explosion in the number of papers compared with how
things were 20 years ago
 Quantity without quality
 The ethics of the publications, the integrity, also of the
publisher and the publication
 Should we review literature quickly and accurately and use
agreed research protocols to make studies more comparable
 Stronger peer review
 Getting reliable peer reviewers, should we pay them? Maybe
but where is the money coming from?
 International accepted code of publishing responsibility
 Encouragement of research reporting the reproducibility of
previously published studies
 Democratisation versus quality and the whole quality issue
 Secondary publishing, the broader use of electronic discus-
sion of recently published studies
 In 20 years’ time will most of the methods sections be in
the form of a video with a short commentary so that people
can see exactly what happened?
 Clinical trial registration
We have a lot of baggage from the past but let us go forward
into the future with good ideas and let’s see collectively in the
next 55 minutes what we can achieve (Figs. 1 and 2).
I would like each of the panellists now just to make very
brief introductory statements. Will [Giannobile], can we start
with you?
Will Giannobile (Editor-in-Chief, Journal of Dental
Research)
First I would like to thank you Kenneth for organising this
gathering and I think that as you had mentioned it was a
couple of years ago that you first brought together many
editors from across the globe looking at dentistry and dental
publications and really getting together as a group under-
standing a lot of the uniqueness of dental publications but also
addressing some of the broader issues that impact all of the
journals across biomedical research. So really we see this as a
gathering with editors and those involved with the peer review
process looking at ways that we can improve the whole
process, understanding the changeability right now in our
current climate and ways that we can work together in
furthering the publication process. So certainly you have
provided a lot of good discussion points and so I am really
looking forward to this session and again thank you for
bringing us together.
Rex Holland (Co-Editor-in-Chief, Archives of Oral
Biology)
The most persistent problem an editor faces is finding quality
referees; this is becoming increasingly difficult partly because
refereeing gets little recognition. The most obvious way
around this problem is to pay referees. Paid reviews would
likely be done first and fast in the hope that one would be
invited again. This would be particularly appreciated in
countries such as the U.S. where faculty are obliged to earn
part of their salary from outside sources. This would also
provide a measurable parameter (earnings) for promotion
Fig. 1 – Professor Eaton (standing) leads the discussion at
the Seattle Meeting.
Fig. 2 – Panel discussion: L-R: Rex Holland (partially
obscured), Peter Robinson (speaking), Will Giannobile,
Stephen Hancocks.
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purposes. This already goes on with some of the newer
journals that extract submission fees.
The second major concern is linked and is the apparently
high level of publishing misconduct. This has attracted much
more attention and there are a number of international groups
addressing it. Particularly interesting is the number of papers
that are now retracted. Not all retractions are due to
misbehaviour but many are. Depressing evidence of this is
available online (http://retractionwatch.wordpress.com,
http://ori.dhhs.gov). Twenty years on will see a reduction of
this problem with the wide availability of anti-plagiarism
software and search engines that can detect duplication and
‘salami’ science.
One other change that would be beneficial would be a
change in attitude of reviewers and editors towards reports
that repeat studies that have already been done and towards
that contain negative but valid data. With, effectively, an
unlimited number of clouds, finding somewhere to publish
these should not be difficult.
Stephen Hancocks (Editor-in-Chief, British Dental
Journal)
Thank you very much Ken and thank you ladies and gentlemen
for coming along today. It is good to see so many of you. I have
absolutely no idea where we will be in 20 years’ time. But I often
think that it is useful when looking ahead to actually look back
20 years and if we look back to 1993 incredibly we wouldn’t even
really have had the internet. We wouldn’t have had e-mail, most
of us wouldn’t have had cell phones or mobile phones and so we
would have been busy faxing one another. There is a gentleman
at the front here looking completely quizzical, it is like what
world did I come from? I lived in a cave just outside London! But the
explosion of technology and of communication, possibilities
that have happened in the last 20 years has been vast. I
remember there was an FDI congress in Amsterdam in 1989 and
editor Helmut Hydt, editor of the Dental Journal of South Africa,
burst into a meeting saying it was all going to change. Helmut
was talking about a page layout programme called PageMaker.
He said ‘‘this is going to change everything we do; it is going to
change everything’’. That was 1989 and now we just take all this
completely for granted. I think that is important because where
we are going to be in 20 years’ time is in a lot of ways going to
depend on what we can actually do technically, physically and
so forth.
But having said that, there are some fundamentals that will
still be in place and they have already been mentioned. One of
course is veracity. How do we know where the truth is? It takes
two people to tell the truth and that is why we have referees. I
am second in the queue after Rex for the thousand pound
refereeing fees that sound great. I’m told it was dollars, you see
it is going down already! So there are some fundamentals, how
do we really sift out the truth? So there are going to be some
fundamentals that I think will still be in place. I think that
there is going to be a lot of things that we are going to have to
carry on adapting to whilst keeping those fundamentals in
place. High up on the agenda are things like plagiarism and so
forth because they are human attributes. They are still going to
be things that we need to take care of.
Peter Robinson (Section Editor, Oral Epidemiology,
BMC Oral Health)
Thank you very much Ken for giving me this opportunity to
talk. I was recently appointed as the section editor for oral
epidemiology and health services research for BMC Oral
Health, which hopefully you all know is an open access
journal. The general model is that authors pay to publish in
BMC Oral Health. That model seems to be a model for the
future. It is difficult to see very far ahead but certainly by the
indication by the number of submissions to the BMC Oral
Health and the other journals in the BMC suite that seems to be
the way ahead. My appointment as section editor marks a
threshold in the number of manuscripts submitted to BMC
Oral Health.
My appointment also marks a real effort by the publishers
to separate the editorial decisions from the revenue stream.
That is to say since BMC generates its revenue by accepting
manuscripts they don’t want to be directly involved in
deciding how many and which ones are accepted.
On-line publication presents an interesting conundrum
and I was pleased to see that Ken had used some of the
information that I had given him, when producing the list of
topics that we might discuss today. For us at BMC quality is
interesting because we are not constrained by space in the
same way as the print journals are. Hence there is less
pressure on us to be selective, unlike the situation say at JDR
(Journal of Dental Research). The general policy is that we will
publish anything that represents an incremental advance. I
am slightly anxious about that partly because I teach critical
appraisal to post-graduates across England and I have
learnt that many readers rely to a greater or lesser extent
on publication as an indication of the quality of what they are
reading. That is to say that appraisal skills amongst readers
are worse than they are amongst reviewers; not universally
good. So there is a great deal of pressure on a journal such as
our own and how we are going to overcome that.
Chair
Thank you panellists for your wise words. Now the floor
is open. We have made a lot of points, and I now call on
you individually to give your opinions. Shall we start with
the peer review situation? That is one of the burning
issues I think. Hello, there yes, Rowena what is your
question?
Rowena Milan (British Dental Journal)
Can I just ask the question to Chris maybe, how many review
requests do you receive per month.
Chris Lynch (Journal of Dentistry)
Me personally?
Rowena Milan
You personally.
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Chris Lynch
Two to three.
Rowena Milan
Right, so in Chris’ world you get paid a thousand dollars per
review, that is two to three thousand dollars, which you would
be quite happy to take up I would expect.
I think that we ought to be careful and think about this, in a
world where some journals will pay reviewers and others
won’t, the journals that don’t are going to have to jump on the
bandwagon first otherwise they are not going to get any
reviews, how is that going to affect academia as a whole in the
world where having two to three thousand dollars a month for
peer reviewing.
Chair
Rowena thank you very much. So what are the implications of
paying reviewers and what they might be? One of them is who
is going to pay and also where is the money coming from
because our current system of subscription to journals doesn’t
really accommodate this.
Ivor Chestnutt (Cardiff University)
In response to the point that is being made about the making
payments to reviewers, assuming that it takes around 3 hours
to do a thorough review, then when one takes into account
university overheads, senior staff salary, etc., then perhaps
one thousand pounds per review is not too wide of the mark.
The issue is that in an era where journals are asking us to
review for free but then also asking us to pay to have articles
available on open access then to me there is an element of
publishers potentially having their cake and eating it so to
speak – a situation that is unsustainable.
Unknown member of the audience
Unfortunately a relatively small number of researchers review
papers. A lot of people say I don’t have time. So I think that if you
for more than once, twice, three times refuse to review papers
it might be an option to block these people from having their
paper published in your journal.
Chair
Yes, well this is an idea which we suggested about two years
ago when we had the inaugural meeting of editors and
publishers and the principle was submit one, review one and
that is one way of looking at it, I think that we would have to
get a consensus amongst all the quality journal publishers and
editors to do that but that could be a way forward, Rex?
Rex Holland
Well the submission fee could balance the refereeing fee and
there is another consideration about reviewing, which is that
there is no credit for it. You come up for 10 year promotion or
whatever, retirement and they count papers, they can count
the number and amount of grants but the contribution to
refereeing is not measurable easily and so it doesn’t count
when it should, it is a very important part of personal
assessment. If there was money involved they could count
that money and it would become measurable and also
certainly in the US a lot of faculty members are obliged to
earn part of their salary, usually that would come from grants
but it could also come from refereeing as well.
Michael Glick (Editor, Journal of the American Dental
Association)
Eight years ago I actually rewarded my reviewers with
continued education credits, so they received something for
it but it didn’t cost me that much. Yes they can do it but we also
actually evaluate the quality of the review and if the quality is
good enough they get the credit, if not they won’t.
Chair
Well I think that is absolutely excellent because we have all
had absolutely dreadful reviews, you know the stupid
comment this is a great paper accept it, which is absolutely
meaningless to us but we all get them don’t we?
Michael Glick
How would you handle accepting payment for reviews and
conflict of interest?
Chair
Well that is an interesting point and I think that if you felt
there was a conflict of interest you would have a reason for not
accepting the review because it could be said that the reviewer
would not be very objective. Clearly if you are working for
another group that is working in a similar area, there is a
potential conflict of interests.
Michael Glick
But what if you perceive there is no conflict and someone else
does? I think that you have to discuss that with other editors.
Editors round here how would you feel about that thought?
Will Giannobile
Yes, this is an interesting discussion. I do think that payment
for reviewing is not very wide spread, and I don’t see it as
actually becoming very common except possibly for the fee-
for-service, for example open access environment I think that
it may come in to play (when authors are paying for
manuscript submissions). It certainly is a form of professional
service just like reviewing grants, writing letters of support for
individuals and as Michael has mentioned there are other
ways I think that we can provide recognition. I think that this
is very important because it does appear to be a thankless
job often times. At this meeting on Friday we have a reviewer
and editorial reception and we publically recognise those
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reviewers who have carried a heavy load in terms of the
reviewing process. Also it is probably on a weekly basis that I
am writing letters of support for those reviewers for their 10-
year promotion process, to recognise that these individuals
have performed reviews.
As Michael has mentioned with his journal we have a
quality assessment, so every review gets what is called an R
score. It is a pretty traditional combination of the quality and
the timeliness of the review. Those are the most important in
our overall assessment of a reviewer. I do like this point of
those individuals who submit articles to the journal should
expect that they would also go into the reviewer pool. Many of
you have been asked to review manuscripts based on those
criteria. But we look at those very closely because we know the
matrix of timeliness of review and getting quality reviews is
critically important from the vantage points of the author and
the journal’s reputation looking to continue to enrich that
pool.
Regarding paying reviewers, I think that what is happening
is that the journal editors and the section editors and with JDR,
all the associate editors, make the final decisions on the large
majority of manuscripts. We have to do heavy triaging of
manuscripts because we know of reviewer fatigue. We cannot
send every manuscript we receive out for peer review and with
JDR approximately 50% of the manuscripts are returned
without external review. The editors make a decision based
on impact or potential methodological issues. We direct the
authors to another type of journal because we do understand it
is such a limited pool of reviewers (that are not able to review
all of the papers we receive). And so the only context that we
have discussed paying reviewers, and I was an associate editor
for a journal that paid biostatisticians in particular, and they
are almost functioning like an associate editor in a way
because of this. It could be viewed as a conflict of interest if you
were just a hired gun to review. We have had some of these
models where there is a very limited pool in certain areas. All
of our clinical trials and systematic reviews are reviewed by
biostatisticians and clinical trialists. Right now, in our current
environment, we have had some discussions at the board level
for you know a very modest stipend because no one is really
doing it for the money. But you can’t ask someone to review 10
papers a month. We do try to never give a reviewer more than
one paper at a time, we sometimes abuse the biostatisticians
in that regard but most everyone else we try to calibrate that.
Unknown member of the audience
Let me throw something else into the midst, if we demand
financial disclosure of individuals that submit, so if you now
receive a thousand dollars, is it ethical not to disclose this in the
same way, as the sponsorship of a study by someone? There is
financial interest because the reviewer is still anonymous and
you still get paid, is that ok? So as a reviewer would you be
willing to have your name associated with review published
with a disclosure that you were paid to review it?
Chair
I think that it is a very interesting point. For openness and
transparency it would be best that the name of the reviewer
was associated with the paper and the fact that they have been
paid for the review. This is what governance and transparency
would suggest.
Steve Rosenstiel (Editor-in-Chief, Journal of Prosthetic
Dentistry)
I think that if we can get closer matches between the peer
reviewers and the subject, that certainly helps and as a
reviewer and as an area that I am working in it is an easier
review, it is probably a more accurate review and I know that
Elsevier has nice software which helps us get a list of
individuals that you might not know personally, might not
have reviewed for your journal before but they are a very close
match to the topic that is being reviewed and I think that is
something in the future that we might be able to get better
peer reviewers even if they are not the familiar faces that we
are currently using.
Chair
Yes I think that a lot of us will have that, we have got little lists,
I know that I have, of particular people who I know to be
reliable and that have their particular topics of knowledge and
I would have thought that, most of you must do that surely
rather than just a of random selection of people.
Steve Mason (Glaxo Smith Kline)
Just a philosophical question really. Do you think that you
might arrive a situation where you actually have professional
reviewers who by virtue of their career and development have
then just simply become a professional reviewer on a
schedule, on a quality? And I think that you know that the
question was raised in terms of 20 years’ time whether that
would be a future stage that could potentially arise?
Chair
Well I think that could be a way forward and certainly people
have recently retired who aren’t totally disenchanted with
dentistry and want a break from the golf or the garden. It might
be a thing that they could do along the way of life, and we are
all living longer. Of course the danger is: are they keeping up-
to-date in their area and this is the problem isn’t it? I mean
when you stop doing clinical dentistry all clinicians say ‘‘oh he
is a dry fingered dentist’’ but actually he might be in a position
that he can read more as a result and be more up-to-date. So it
is an interesting development and I think that could happen,
yes you have got a point there.
Gordon Proctor (co-Editor-in-Chief, Archives of Oral Biology)
You mentioned the Elsevier software and I was going to make
the same point. It provides a very good match between
reviewer, potential reviewer, people who you may not have
heard of but who are publishing in exactly the right areas for
the sort of paper that has been submitted. On that basis I don’t
see us going to a situation where we will be paying the
reviewers in the future. The whole review process would
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become democratised as there are lots of potential reviewers
out there. The papers you generally have a problem with are
those which don’t quite fit into a clear category and may be a
niche that could be a problem sometimes. Generally there is
plenty of choice of potential reviewers. You just have to give
them a try, people who have submitted their own papers and I
guess once you have tried them and it has been a poor review
then you don’t go back there again.
Will Giannobile
I think that it is a very good point and it is something that we
look at in terms of it is a key point if you have, you know if
there is an interesting paper, you know those of us involved in
science typically will want to review it, if it is very interesting,
especially if you are active in the field you can benefit and learn
in the process and I think that is one of the most valuable
aspects. We tend to see the papers just in a rough estimate,
those papers that tend to be more impactful people may agree
to review very quickly and then on the opposite side if we
cannot get a reviewer and I was just talking to an associate
editor, they had gone through 12 individuals and so if these are
experts who don’t want to review it then those papers
probably should just be triaged. So it is a balance, if it is
pulling teeth to try to get reviewers, maybe this is not a strong
paper for the journal.
Chair
There is another aspect, as Peter was saying about teaching
critical appraisal to post grads. We are all doing this now and
so that way is the way forward I think that we are actually
training people to review because in the past most of us were
just sent a paper and it was presumed that our expertise was
such that we could get on and review it. So that might well be a
helpful way forward, I don’t know if anybody has any
comments on this idea?
Stephen Hancocks
I think Ken if I could just come in, certainly on the British
Dental Journal we do a lot of the positive sounding things
that have been mentioned in the room already in terms of CE
or CPD credits, we don’t need to do that because our General
Dental Council (the national regulatory body) recognises
reviewing as a CE activity. I think that there is a parallel with
tennis linesmen and umpires isn’t there, I think that years
ago we had this debate about whether it should be amateur
people who judge the lines at Wimbledon and now I think
that they are all professional, am I correct? Are there tennis
fans?
Chair
Well actually I can help you there because I have friends
who have been referees, umpires and line judges and some
are professional but the majority are actually still amateurs
who have had intensive training. There is a hierarchy and
pecking order and you don’t get to judge the lines at
Wimbledon until you have actually worked your way
through the minor and lesser tournaments. In short there
is formal training.
Stephen Hancocks
Right, well thanks, that is, I am sure Andy Murray will be very
assured.
The formal training was the point that I was going to
make. None of this is an exact science and in fact science
itself isn’t exact. The measurement is exact but what isn’t
exact is the interpretation of it and that is actually what we
are dealing with when publishing research. We are dealing
with somebody’s opinion on what it is they have just
observed and measured. I was invited to a celebration two
or three years ago for the Cochrane Foundation to do my
usual thing of introducing the proceedings and making a few
sideways remarks. I said ‘the thing that amuses me about
Cochrane reviews is that they start with a particular subject and
find that there are 350 papers on this subject. Then they apply their
really strict criteria and that reduces it to 104 and then they go
through and look at it again and it reduces it to 76, and then it goes
down to six and then they read these six and they say on the basis of
this they say what we need is more research!’ And everybody in
the audience chuckled merrily and said ‘Oh it’s Stephen taking
a sideways look at things again. Thank you very much Stephen.’
Now over to our first panel of the day for orthodontists. The
orthodontist came on and said ‘well we started with 376 papers,
and then we reduced it to 17 and then we reduced it to three and our
conclusion was that there wasn’t enough research to make a decision
one way or the other and so we need more research.’ And nobody
laughed. They were like ‘yes that is very true, that is very true.’
So none of this is exact and it is not exact on the side of the
people writing, doing research and writing it. It is also not exact
on our side either. Really what we have been discussing today is
how we can make checks and balances to make sure that what
we publish is about the best it can be both in terms of the quality
of the research and its relevance and also the things that we
have done in order to try and make it publishable, useful,
readable and so forth. I don’t think that by paying referees, by
having all these declarations that you are ever going to get to the
truth of conflict of interest, where people just frankly don’t like
this author because once they pushed into the queue at the
salad bar in Selfridges or something. You are never going to find
that stuff out, it is human nature. I enjoy the novels of Agatha
Christie, particularly Miss Marple detective novels. What we are
talking about here is detection as well, investigation, based a lot
of her observations of what went on in her English country
village. It goes on in my English country village. It is always the
same people after a council meeting who put the chairs away.
There are 500 people in the village but only three put the chairs
away. It’s the same in our world. There are 500 people who know
all about the histopathology of gammaglobulin but only two will
ever review papers for you. So again it is about human nature.
We are never going to get it absolutely right but we as editors
and publishers need to make sure that what we do is as right and
as balanced as it can be and I think that all these things that we
have been talking about today add into that mix and it is terrific
that we are able to talk about them openly and then be able to
apply them with the various techniques and methods that we
have got.
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Chair
Well Stephen thank you very much for that, I am going to
move us onto another topic that you have introduced: the
veracity and integrity of the author, publication and publisher.
We have been talking about the problems with plagiarism, is it
a growing problem? Can we improve the detection software?
One of the universities where I have an honorary chair, all the
assignments that our students do go through plagiarism
software as a matter of course. Does that happen at your
universities?
Rex Holland
They have another software package and I have been able to
avoid being a detective!
Chair
I think that it might be useful just exploring this whole
business about fraud and publication, plagiarism and all
the other difficulties there, and Rex you have made some
opening comments on that very topic earlier on, so what does
the audience feel about this? Do you think it is a growing
problem?
Michael Glick
I can only tell what we get, I probably read around 1300
manuscripts a year and it is very clear, without mentioning
countries or cultures, that in some cultures plagiarism is
looked upon more as something positive than negative, let’s
put it that way. Some countries where I had 90% of
submissions are plagiarised and the question is then how
much identification, how much overlap is considered plagiar-
ism? Some people say well you can copy methods? how can I
write it any other way, this is plagiarism. Well maybe that is
copyright rather than plagiarism, so I think that we have
enormous problem which is going to have even more
problems in the future of plagiarism.
Peter Robinson
I agree with Michael, except that I see it more as a collision of
academic cultures. I am sorry to sound so politically correct
about this, but I have a lot of students from educational
cultures who do this a lot. As it is a collision of cultures, as soon
as we start to use the word ‘‘plagiarism’’ it is a form of
imperialism really that we are imposing a set of values on
people, and I don’t think that helps us solve the problem. Now
maybe our standard is what they aspire to but it is really very
difficult and I think that we would have to think of seeing it in
other ways than we are right and they are wrong. Instead,
perhaps we should see it as an educational issue and that we
need to harmonise standards.
Michael Glick
Can I respond to that, I have had a discussion with an editorial
board a couple of years ago about an Independent Review
Board (IRB), and I said can we accept an IRB that is different to
ours if it comes from another country, and it is exactly the
same thing, the same issue.
And I got a publication from a country that didn’t mention
an IRB or its equivalent (an Ethics Committee) and I rejected it
and then I subsequently received the review board approval
after this rejection with the signature of the university. This
was acceptable to the university concerned but was it ethically
acceptable? I think that if they publish in our journals then we
set the standard and that is it. It is our definition, unfortu-
nately.
Rex Holland
It is really just a question of attribution isn’t it, I mean copying
is copying, if you are in school and you look over and copy
something that your neighbour has written it is wrong.
However, in some cultures it is seen as ‘homage’! If you miss
out a pronoun in some countries in your final exam, you know
from the original text, you will lose marks. It is homage.
Jane Ryley (Elsevier)
We have had some recent discussions, clearly with the advent
of all these electronic submission systems it has allowed for
auto submission of papers to become much more global, we
are seeing a lot of it (plagiarism) over all of our dental journals.
A couple of recent examples, just to echo what you said, is that
it is considered by some of these students if they are called on
in papers, they consider it a form of flattery and they are
paying homage to their professors and respect the academics
within their specialities, so I think that it is an ongoing
problem.
Chair
It is, it is very difficult but we hope that with the passage of
time and internationalisation that we can improve things
there because it is a big problem. Can I move us on then and I
think this topic here is very relevant because this is an IADR
meeting and this is where it could happen perhaps. It is an
agreement to standardise research protocols to make studies
more comparable. I would look perhaps to IADR and the
different interest groups there to think about this but what do
you think about that idea?
Will Giannobile
That’s extremely difficult to do. Anytime that I have been
involved in some sort of consensus meeting on the develop-
ment of guidelines we can never get people to agree on those
sorts of things. So it seems almost impossible, and the
examples that you give with evidence based dentistry in trying
to perform a systematic review and then meta-analysis, going
from a gazillion papers and then you have three that fit within
a specific protocol. Within the different disciplines of research
methodology and education training programmes at univer-
sities within the educational systems it may be possible, but I
think for the editors and the journals to mandate this sort of
thing it becomes very difficult.
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Chair
I think that I agree with you but I would say that epidemiology
is one area where you can possibly note some progress and so
that you are actually using the same systems for assessing
disease in the population, and that is one area where we could
do quite a lot more than we have been doing.
Peter Robinson
When it comes to epidemiological studies we now require the
following of STROBE guidelines for observational studies,
clinical trial registration, CONSORT guidelines and these have
gradually gotten into many of the different journal systems
requiring them and that does improve journal quality. But
those guidelines also provide a lot of flexibility in terms of how
the materials are presented. So guidelines have already been a
positive step to address some of the quality related issues that
you are bringing up.
Chair
And looking to the next 20 years as STROBE and CONSORT have
been developed in the last 10 years might there be something
else happening. Is anybody in the audience working on
anything like that at present that they would bring to us?
Unidentified member of the audience
I think it is getting back to the idea of you know globalisation of
information and how information could be useful outside of
the United States or you know, trying to get a protocol for any
sort of innovation from outside the mainstream where there
are new ideas. Innovation can happen outside of that
mainstream, and so trying to set this up again is not respecting
the fact that new knowledge, new protocols can come from
outside and I think that we have to be careful. Yes 90% of the
journals come from the United States, However, 90% of the
work probably does not come from the United States, and a lot
of comes from the western world.
Chair
I think that your data are wrong. I remember reading Will’s
paper that he sent me and it is not 90% from the United States
by any means. The percentage has actually declined has it not
Will over the last 20 years? What was it, about 71%, 20 years
ago and it is now about 30%. So there has been a big change.
However, I think that you are absolutely right, any guideline
can be very limiting to new techniques and new knowledge
but the point is, is that the guideline is not a law, it is not
absolute and if you don’t follow the guideline as long as you
give a clear indication of why you haven’t followed the
guideline then that should be acceptable but you have to give
that explanation. This is the way to overcome the problem.
Stephen Hancocks
I think that is an excellent example of where judgement
comes in rather than just is it black or is it white, does it fall
one side of the barrier and what we are talking about
again here is opinion, human nature, interpretation and
therefore one would hope that the systems that we have got
in place now, certainly in the British Dental Journal, would
actually recognise that here was something that didn’t quite
fit the mould. We would want to recognise something as
different but not necessarily a bad thing by asking ‘‘is that
actually where this particular branch of dental science is
going?’’ It is that classic thing of you don’t want, as an
editor, to be the guy that turned down the speaking movies,
don’t want to be the guy that turned down the paper that
might have changed the whole of dental science. So I take
your point absolutely that if we are too rigid about these
things then we could be missing some very important
research and data.
Rowena Milan
I am interested in the panel’s views on what would be
better than reporting protocols, I mean the number of times
that you look at a review and a large number of studies
have to be discarded purely because they haven’t said what
it was that they did and so you can’t compare. And so even if
there is not an agreed protocol for carrying out the study
itself, as long as you reported exactly what you have
done then that would be a step forward, what would the
panel do?
Peter Robinson
It is getting better isn’t it though? Stephen’s jokes aside, things
like CONSORT and STROBE have pushed quality forwards.
With a PhD student planning studies now, we give them
CONSORT and say ‘‘Make sure that your trial meets these
criteria, both when you plan it and when you report it’’. So to
give an example, I have been involved in the Cochrane reviews
of powered toothbrushes. In our first iteration, published
about 10 years ago, there were only 40 papers and that
represented all of humanity’s work on comparing powered
with manual toothbrushes. And yet in the next round there
will be nearly as many again so that there have been really as
many good quality studies in the last 10 years as there had
been in the previous two millennia.
Brenda Heaton (Boston University)
I think that we have come a long way since STROBE and
CONSORT reporting guidelines but I think that there could be a
higher level of rigour from the review process or even on the
submission process and be clearer on design. You see so many
studies, case control studies that are not case control studies
by design which makes things like reviews very, very difficult
and not to mention better analysis or other things. I think that
is something very simple to be taken care of in the review
process or the submission process too, in the same way we use
biostatisticians use epidemiologists.
Bring a little bit more clarity to design because I think
that limitations are under reported because of lack of clarity
and the design for example and a lot of things get
promoted.
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Rex Holland
Isn’t that the real value of many systematic reviews? Not that
they come up with a concrete result but that they find out the
lack of data and maybe they should just try and emphasise
more the standardisation of criteria. Anybody who has ever
done one will realise that they throw away probably 10 times
as much data as they include. The interesting thing is that
somebody said that they had, the second time around in a
study they found as many new worthwhile papers to include
in a systematic review and I have had that experience too and I
suspect a lot of people have. So maybe it is the first systematic
review that needs to be done and then the worthwhile ones
will be done later.
Michael Glick
On the same topic and I think that you have brought out
something very important, we don’t tend to publish negative
results, so if I do a systematic review I am not going to find it. I
call this the evil dolphin theory, you know dolphin are
wonderful animals because if you fall overboard and they save
you but there are these evil dolphins that take you out to sea
and you drown and you never find out about those dolphins.
And it’s the same thing here, we do our systematic review but
as publishers we don’t publish negative results and we are
never going to get to the truth. And I would challenge all of us
to stop doing it.
It would be interesting to know how many people do not
publish negative results because there is nothing wrong with
negative results as long as the controls are adequate so that we
know that that is the real result. It wouldn’t be worth doing the
experiment if there wasn’t the possibility of having a negative
result.
Jane Ryley
Yes my question is actually directed at Will. I know that you
spoke at the ADA within the last couple of weeks regarding
registration of clinical trials. Could you give us your thinking is
on that.
Will Giannobile
Yes there was a conference held in Chicago a couple of weeks
ago that Michael Glick organised to bring together some of the
manufacturing communities and dental editors regarding
clinical trial registration. Clinical trial registration is a require-
ment for the Journal of Dental Research and many other
journals. So there is a consortium of journals in the early 2000s
that actually came together, the Lancet and the New England
Journal, requiring it. The reason for clinical trial registration is to
simplify things, to provide clarity and transparency on the
design of clinical trials in terms of outcome measures. A priority
defining primary outcome measures as x and y is designed to
help promote patient safety because of unfortunate examples
within the drug manufacturer community where the primary
outcomes were changed.
That is one part of it. The second part is to help patients to
become more involved in the process and so during
recruitment some patients will enquire regarding the process.
So we are doing it in terms of clarity and it helps the editors a
great deal when this is done a priority to identify what those
outcome measures are and then the whole series of secondary
analysis can be done. We started implementing this, almost
two years ago. It wasn’t requiring a priority registration
because I think that dental community is behind the medical
establishment, but we are requiring clinical trial registration
and we anticipate in the next year that it would be a priority
registration at the time of the initiation of the study.
Michael you might want to add, as you compiled a lot of the
conclusions from that meeting, anything else that you would
want to include, I know JADA is also requiring clinical trial
registration.
Michael Glick
They felt that by doing this they would improve the quality of
information and could they be excluded from this require-
ment and that is what the discussion was all about.
Chair
Well now we are getting near to the end of the session and I
know that a lot of us are going to rush off to other things at half
past one. There are three things which I need to say.
The first is that to thank you so much for coming, we had an
amazing turnout, a completely full room and people standing
at the back. I hope that it has met your expectations. This was
the third meeting that we have held at an IADR meeting for
editors, associate editors, publishers and those interested in
the publication process.
The second is that I would like to float the idea, would you
collectively feel that it would be a good thing to approach IADR
to ask if we can have a regular session. I think that if we do then I
will go for this sort of time because later on in the programme it
gets incredibly difficult as there is so many clashes with others
things Is that the feeling from the audience, would you like that
to happen? Anybody think that it is not a good idea? OK well I
will chat with the panellists and we will get something together.
We hopefully have all written down your names and email
addresses because it is always a nightmare trying to find the list
from a year ago or two years ago and make sure that everybody
knows about it other than just seeing it in the programme. If you
have got any ideas I will leave my address on the screen. Do
please send me an email, tell me what you think, what your
ideas are and we will try and take this forward.
The third is now that red arrow (computer screen cursor)
has poised over the little thing which said funding and that is
to remind me, we have a sponsor for today. Because the cost of
recording all this and all the technical things is quite
substantial. A big thank you to Stephen Hancocks’ organisa-
tion for providing the sponsorship and as they say, used to say
in American television at the end of a programme and now a
few words from our sponsor.
Stephen Hancocks
Thank you very much Ken and I echo all of Ken’s words really, I
am taking my British Dental Journal hat off now and putting
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my own publishing company hat on, Stephen Hancocks
Limited, and if I can just get you to take one of these and
pass them around, which I think and hope is very relevant
to IADR. It is called World Dental Posters and it is at
www.worlddentalposters.com. Basically it is an open access
site for anybody who has had a poster presented at a peer-
reviewed meeting, we get back to that concept again of peer-
reviewed meeting, to upload their poster. The first 100 posters
are free and thereafter it will be £25 or $40 per poster, so again
a modest sum I think from authors. The posters will go onto
the open access site, they will be listed according to author’s
name, title and key words and they will be up there for as
long as the author wants them to be up there, there will be no
further charge of any sort. So the idea really is to get as much
science out there as possible to as many people as possible as
economically as possible, the idea came from my partner who
said what happens to all those old posters that we see at
IADR and all the other meetings around the world? The
answer which came back from many poster authors was, well
they end up rolled up in the back of our wardrobe or in the
corner of the department’s cupboards or tripping up our
secretaries or whatever, so to actually have a longer life of
these posters would be a terrific idea. So that is my
message and I am delighted that my company was able
to help to sponsor today’s meeting, do please go on line,
have a look, www.worlddentalposters.com and we hope to see
lots of your posters on the site very soon. Thank you very
much.
Chair
Well Stephen thank you very much for all the sponsorship and
also a big thank you to our technician there, hopefully we
haven’t caused him to many problems and hopefully he is
going to give me the disc and so there is a clear record of what
we have said and we will try and publish these proceedings,
thank you all very much.
End of meeting
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